Tianling Chen
Impact in
- Oncology top 5%
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 3
-
- Advanced Battery Materials and Technologies 8
- Advancements in Battery Materials 6
- Advanced battery technologies research 3
- Co-authors
- Horst Schran (3 shared papers)D A Noe (2 shared papers)Robert B. Brundrett (2 shared papers)Ross C. Donehower (4 shared papers)Patricia LoRusso (1 shared paper)Christina Ravera (1 shared paper)Andrej Skerjanec (1 shared paper)Peiming Ma (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)Nano Energy (2 papers)BMC Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Tianling Chen
39 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Oncology 676
- Hematology 178
- Radiology, Nuclear Medicine and Imaging 226
- Orthopedics and Sports Medicine 80
- Genetics 91
Countries citing papers authored by Tianling Chen
This map shows the geographic impact of Tianling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianling Chen more than expected).
Fields of papers citing papers by Tianling Chen
This network shows the impact of papers produced by Tianling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianling Chen. The network helps show where Tianling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Tianling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 312 | |
| 2 | 2003 | 177 | |
| 3 | 2010 | 174 | |
| 4 | A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. | 2001 | 166 |
| 5 | 1989 | 101 | |
| 6 | 2009 | 85 | |
| 7 | 2005 | 80 | |
| 8 | 2000 | 56 | |
| 9 | 1994 | 48 | |
| 10 | 1988 | 46 | |
| 11 | 2024 | 36 | |
| 12 | 2022 | 34 | |
| 13 | 2024 | 33 | |
| 14 | 2000 | 32 | |
| 15 | 2003 | 32 | |
| 16 | 2006 | 27 | |
| 17 | 2024 | 25 | |
| 18 | 2025 | 23 | |
| 19 | 2025 | 21 | |
| 20 | Characterization of CAT-8015: A Pseudomonas exotoxin based immunotoxin for the treatment of CD22-related hematological malignancies | 2006 | 13 |
About Tianling Chen
Tianling Chen is a scholar working on Oncology, Electrical and Electronic Engineering, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advanced Battery Materials and Technologies (8 papers), Advancements in Battery Materials (6 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (3 papers), Advanced battery technologies research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Chemical Synthesis and Characterization (2 papers). The work is most often cited by research in Oncology (676 citations), Hematology (178 citations), Radiology, Nuclear Medicine and Imaging (226 citations), Orthopedics and Sports Medicine (80 citations) and Genetics (91 citations). Tianling Chen has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Horst Schran, D A Noe, Robert B. Brundrett, Ross C. Donehower, Patricia LoRusso, Christina Ravera, Andrej Skerjanec, Peiming Ma, Robert Vescio and Susan Goodin. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Nano Energy and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.